TAKE Solutions Share Price in Focus; Unveils AI Platform to Transform India's $370 Billion Healthcare Sector

TAKE Solutions Limited has announced plans to build a Unified AI Platform aimed at transforming India's healthcare ecosystem, in alignment with the IndiaAI Mission. 

Platform Objectives and Scope 

The platform will serve as a digital infrastructure layer, enabling hospitals, labs, and clinics to adopt AI solutions. It addresses diagnostics, clinical decision support, hospital operations, clinical trials, and preventive care, targeting both urban and underserved areas. 

Strategic Alignment with National Goals 

This initiative supports the government's vision of a 'Viksit Bharat' by bridging healthcare gaps through scalable digital public infrastructure. It aims to reduce technology adoption barriers, making advanced healthcare accessible and affordable nationwide. 

Market Impact and Growth Potential 

With India's healthcare sector valued at $370 billion and preventive healthcare at $197 billion, the platform positions TAKE Solutions as a key enabler in the AI-driven healthcare transformation. The global AI healthcare market is projected to exceed $180 billion by 2030, presenting significant growth opportunities. 

Revenue and Societal Benefits 

By onboarding healthcare providers, the platform will generate scalable revenues while advancing inclusive growth and technological self-reliance under the IndiaAI Mission. It addresses critical use cases like diagnostics automation and clinical trial optimization. 

Read More: ThirdAI Raises $3 Million Seed Funding for Semiconductor AI Solutions! 

Take Solutions Share Price Performance  

As of February 18, 2026, at 9:29 AM, Take Solutions share price on NSE was trading at ₹48.01 up by 1.09% from the previous closing price.  

Conclusion 

TAKE Solutions' Unified AI Platform initiative aims to revolutionize India's healthcare delivery through democratized AI access, supporting the nation's socio-economic and technological advancement goals. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.